US Stock MarketDetailed Quotes

Kestra Medical Technologies (KMTS)

Watchlist
  • 19.740
  • +0.980+5.22%
Close Apr 14 16:00 ET
  • 19.740
  • 0.0000.00%
Post 20:01 ET
1.15BMarket Cap-7.77P/E (TTM)

Kestra Medical Technologies (KMTS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2026
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
Total revenue
62.70%24.55M
53.40%22.57M
51.55%19.37M
115.05%59.82M
71.40%17.23M
82.31%15.09M
14.71M
12.78M
264.53%27.81M
10.05M
Operating revenue
62.70%24.55M
53.40%22.57M
51.55%19.37M
115.05%59.82M
71.40%17.23M
82.31%15.09M
--14.71M
--12.78M
264.53%27.81M
--10.05M
Cost of revenue
36.32%11.65M
25.46%11.14M
22.58%10.52M
29.70%35.61M
10.89%9.6M
15.49%8.54M
8.88M
8.58M
50.17%27.45M
8.66M
Gross profit
97.13%12.91M
95.95%11.42M
110.74%8.85M
6,587.85%24.21M
446.39%7.63M
643.98%6.55M
5.83M
4.2M
103.40%362K
1.4M
Operating expense
75.60%47.67M
72.97%43.18M
66.71%37.73M
52.87%130.59M
156.81%55.85M
30.36%27.15M
24.96M
22.63M
22.44%85.43M
21.75M
Selling and administrative expenses
79.45%42.7M
78.52%38.3M
75.42%33.73M
64.35%114.94M
181.50%50.46M
39.23%23.8M
--21.46M
--19.23M
29.48%69.94M
--17.93M
Research and development costs
48.29%4.97M
39.01%4.88M
17.54%4M
1.05%15.65M
40.96%5.39M
-10.23%3.35M
--3.51M
--3.4M
-1.69%15.49M
--3.82M
Operating profit
-68.75%-34.77M
-65.96%-31.76M
-56.68%-28.88M
-25.06%-106.38M
-136.93%-48.21M
-3.28%-20.6M
-19.13M
-18.43M
-5.77%-85.06M
-20.35M
Net non-operating interest income expense
123.81%275K
92.70%-105K
113.88%255K
27.21%-4.54M
94.63%-104K
30.04%-1.16M
-1.44M
-1.84M
-10.68%-6.23M
-1.94M
Non-operating interest income
244.43%2.16M
104.56%1.8M
5,756.76%2.17M
--3.2M
--1.66M
--628K
--878K
--37K
--0
--0
Non-operating interest expense
5.89%1.89M
-17.95%1.9M
2.03%1.91M
24.14%7.73M
-9.04%1.76M
8.00%1.78M
--2.32M
--1.87M
10.68%6.23M
--1.94M
Other net income (expense)
2,293.33%359K
-2,127.50%-891K
5,995.83%2.83M
1.32%-2.77M
-9,874.07%-2.69M
287.50%15K
-40K
-48K
-253.42%-2.8M
-27K
Gain on sale of security
----
----
----
---2.65M
----
----
----
----
----
----
Other non- operating income (expenses)
2,293.33%359K
-2,127.50%-891K
5,995.83%2.83M
95.79%-118K
-66.67%-45K
287.50%15K
---40K
---48K
-253.42%-2.8M
---27K
Income before tax
-56.99%-34.13M
-58.89%-32.75M
-26.96%-25.79M
-20.81%-113.68M
-128.63%-51.01M
-0.63%-21.74M
-20.61M
-20.32M
-11.72%-94.1M
-22.31M
Income tax
94.44%35K
325.00%34K
371.43%33K
462.50%135K
477.78%102K
28.57%18K
8K
7K
60.00%24K
-27K
Net income
-57.02%-34.17M
-58.99%-32.79M
-27.08%-25.83M
-20.92%-113.81M
-129.36%-51.11M
-0.65%-21.76M
-20.62M
-20.32M
-11.73%-94.12M
-22.28M
Net income continuous Operations
-57.02%-34.17M
-58.99%-32.79M
-27.08%-25.83M
-20.92%-113.81M
-129.36%-51.11M
-0.65%-21.76M
---20.62M
---20.32M
-11.73%-94.12M
---22.28M
Minority interest income
0
0
0
-250K
-253K
-439K
Net income attributable to the parent company
-58.85%-34.17M
-60.96%-32.79M
-29.88%-25.83M
-20.92%-113.81M
-133.59%-52.05M
0.51%-21.51M
-20.37M
-19.88M
-11.73%-94.12M
-22.28M
Preferred stock dividends
83.32%12.32M
65.05%3.29M
83.44%3.32M
3.32M
2.38M
168.95%6.72M
1.99M
Other preferred stock dividends
Net income attributable to common stockholders
-37.58%-34.17M
-38.39%-32.79M
-15.98%-25.83M
-25.08%-126.14M
-127.96%-55.34M
-5.98%-24.83M
-23.69M
-22.27M
-16.26%-100.84M
-24.28M
Basic earnings per share
-21.68%-0.61
46.22%-0.64
-11.23%-0.5
-1.16%-5.13
-81.01%-2.21
57.45%-0.5013
-1.19
-0.4495
-16.26%-5.0711
-1.2209
Diluted earnings per share
-21.68%-0.61
46.22%-0.64
-11.23%-0.5
-1.16%-5.13
-81.01%-2.21
57.45%-0.5013
-1.19
-0.4495
-16.26%-5.0711
-1.2209
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Jan 31, 2026(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024
Total revenue 62.70%24.55M53.40%22.57M51.55%19.37M115.05%59.82M71.40%17.23M82.31%15.09M14.71M12.78M264.53%27.81M10.05M
Operating revenue 62.70%24.55M53.40%22.57M51.55%19.37M115.05%59.82M71.40%17.23M82.31%15.09M--14.71M--12.78M264.53%27.81M--10.05M
Cost of revenue 36.32%11.65M25.46%11.14M22.58%10.52M29.70%35.61M10.89%9.6M15.49%8.54M8.88M8.58M50.17%27.45M8.66M
Gross profit 97.13%12.91M95.95%11.42M110.74%8.85M6,587.85%24.21M446.39%7.63M643.98%6.55M5.83M4.2M103.40%362K1.4M
Operating expense 75.60%47.67M72.97%43.18M66.71%37.73M52.87%130.59M156.81%55.85M30.36%27.15M24.96M22.63M22.44%85.43M21.75M
Selling and administrative expenses 79.45%42.7M78.52%38.3M75.42%33.73M64.35%114.94M181.50%50.46M39.23%23.8M--21.46M--19.23M29.48%69.94M--17.93M
Research and development costs 48.29%4.97M39.01%4.88M17.54%4M1.05%15.65M40.96%5.39M-10.23%3.35M--3.51M--3.4M-1.69%15.49M--3.82M
Operating profit -68.75%-34.77M-65.96%-31.76M-56.68%-28.88M-25.06%-106.38M-136.93%-48.21M-3.28%-20.6M-19.13M-18.43M-5.77%-85.06M-20.35M
Net non-operating interest income expense 123.81%275K92.70%-105K113.88%255K27.21%-4.54M94.63%-104K30.04%-1.16M-1.44M-1.84M-10.68%-6.23M-1.94M
Non-operating interest income 244.43%2.16M104.56%1.8M5,756.76%2.17M--3.2M--1.66M--628K--878K--37K--0--0
Non-operating interest expense 5.89%1.89M-17.95%1.9M2.03%1.91M24.14%7.73M-9.04%1.76M8.00%1.78M--2.32M--1.87M10.68%6.23M--1.94M
Other net income (expense) 2,293.33%359K-2,127.50%-891K5,995.83%2.83M1.32%-2.77M-9,874.07%-2.69M287.50%15K-40K-48K-253.42%-2.8M-27K
Gain on sale of security ---------------2.65M------------------------
Other non- operating income (expenses) 2,293.33%359K-2,127.50%-891K5,995.83%2.83M95.79%-118K-66.67%-45K287.50%15K---40K---48K-253.42%-2.8M---27K
Income before tax -56.99%-34.13M-58.89%-32.75M-26.96%-25.79M-20.81%-113.68M-128.63%-51.01M-0.63%-21.74M-20.61M-20.32M-11.72%-94.1M-22.31M
Income tax 94.44%35K325.00%34K371.43%33K462.50%135K477.78%102K28.57%18K8K7K60.00%24K-27K
Net income -57.02%-34.17M-58.99%-32.79M-27.08%-25.83M-20.92%-113.81M-129.36%-51.11M-0.65%-21.76M-20.62M-20.32M-11.73%-94.12M-22.28M
Net income continuous Operations -57.02%-34.17M-58.99%-32.79M-27.08%-25.83M-20.92%-113.81M-129.36%-51.11M-0.65%-21.76M---20.62M---20.32M-11.73%-94.12M---22.28M
Minority interest income 000-250K-253K-439K
Net income attributable to the parent company -58.85%-34.17M-60.96%-32.79M-29.88%-25.83M-20.92%-113.81M-133.59%-52.05M0.51%-21.51M-20.37M-19.88M-11.73%-94.12M-22.28M
Preferred stock dividends 83.32%12.32M65.05%3.29M83.44%3.32M3.32M2.38M168.95%6.72M1.99M
Other preferred stock dividends
Net income attributable to common stockholders -37.58%-34.17M-38.39%-32.79M-15.98%-25.83M-25.08%-126.14M-127.96%-55.34M-5.98%-24.83M-23.69M-22.27M-16.26%-100.84M-24.28M
Basic earnings per share -21.68%-0.6146.22%-0.64-11.23%-0.5-1.16%-5.13-81.01%-2.2157.45%-0.5013-1.19-0.4495-16.26%-5.0711-1.2209
Diluted earnings per share -21.68%-0.6146.22%-0.64-11.23%-0.5-1.16%-5.13-81.01%-2.2157.45%-0.5013-1.19-0.4495-16.26%-5.0711-1.2209
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More